Tullis Growth Fund Ii, L.p. - Net Worth and Insider Trading
Tullis Growth Fund Ii, L.p. Net Worth
The estimated net worth of Tullis Growth Fund Ii, L.p. is at least $2 Million dollars as of 2024-05-04. Tullis Growth Fund Ii, L.p. is the 10% Owner of Exagen Inc and owns about 1,543,155 shares of Exagen Inc (XGN) stock worth over $2 Million. Details can be seen in Tullis Growth Fund Ii, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tullis Growth Fund Ii, L.p. has not made any transactions after 2023-06-15 and currently still holds the listed stock(s).
Transaction Summary of Tullis Growth Fund Ii, L.p.
Tullis Growth Fund Ii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tullis Growth Fund Ii, L.p. owns 1 companies in total, including Exagen Inc (XGN) .
Click here to see the complete history of Tullis Growth Fund Ii, L.p.’s form 4 insider trades.
Insider Ownership Summary of Tullis Growth Fund Ii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XGN | Exagen Inc | 2023-06-15 | 10 percent owner |
Tullis Growth Fund Ii, L.p. Latest Holdings Summary
Tullis Growth Fund Ii, L.p. currently owns a total of 1 stock. Tullis Growth Fund Ii, L.p. owns 1,543,155 shares of Exagen Inc (XGN) as of June 15, 2023, with a value of $2 Million.
Latest Holdings of Tullis Growth Fund Ii, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XGN | Exagen Inc | 2023-06-15 | 1,543,155 | 1.40 | 2,160,417 |
Holding Weightings of Tullis Growth Fund Ii, L.p.
Tullis Growth Fund Ii, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Tullis Growth Fund Ii, L.p. has made a total of 1 transactions in Exagen Inc (XGN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Exagen Inc is the acquisition of 167 shares on June 15, 2023, which cost Tullis Growth Fund Ii, L.p. around $519.
Insider Trading History of Tullis Growth Fund Ii, L.p.
- 1
Tullis Growth Fund Ii, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Tullis Growth Fund Ii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tullis Growth Fund Ii, L.p. is -24.53%. GuruFocus also compares Tullis Growth Fund Ii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Tullis Growth Fund Ii, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Tullis Growth Fund Ii, L.p.'s insider trading performs compared to the benchmark.
Performance of Tullis Growth Fund Ii, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -16.15 |  | | | | |
| Relative Return to S&P 500(%) | -17.95 | | | | | |
Tullis Growth Fund Ii, L.p. Ownership Network
Tullis Growth Fund Ii, L.p. Owned Company Details
What does Exagen Inc do?
Who are the key executives at Exagen Inc?
Tullis Growth Fund Ii, L.p. is the 10 percent owner of Exagen Inc. Other key executives at Exagen Inc include Chief Financial Officer Kamal Adawi , director & President and CEO John Aballi , and Chief Operating Officer Mark Hazeltine .
Exagen Inc (XGN) Insider Trades Summary
Over the past 18 months, Tullis Growth Fund Ii, L.p. made 1 insider transaction in Exagen Inc (XGN) with a net purchase of 167. Other recent insider transactions involving Exagen Inc (XGN) include a net sale of 25,343 shares made by Kamal Adawi , a net purchase of 56,181 shares made by John Aballi , and a net sale of 5,821 shares made by Mark Hazeltine .
In summary, during the past 3 months, insiders sold 19,522 shares of Exagen Inc (XGN) in total and bought 0 shares, with a net sale of 19,522 shares. During the past 18 months, 64,983 shares of Exagen Inc (XGN) were sold and 90,167 shares were bought by its insiders, resulting in a net purchase of 25,184 shares.
Exagen Inc (XGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Exagen Inc Insider Transactions
Tullis Growth Fund Ii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Tullis Growth Fund Ii, L.p.. You might contact Tullis Growth Fund Ii, L.p. via mailing address: 11770 Us Hwy 1, Ste 503, Palm Beach Gardens Fl 33408.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
